Exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome: the need for a revised paradigm approach
- PMID: 22520116
- PMCID: PMC9942514
- DOI: 10.1053/j.jvca.2012.03.008
Exogenous surfactant therapy in acute lung injury/acute respiratory distress syndrome: the need for a revised paradigm approach
Comment on
-
Exogenous surfactant may improve oxygenation but not mortality in adult patients with acute lung injury/acute respiratory distress syndrome: a meta-analysis of 9 clinical trials.J Cardiothorac Vasc Anesth. 2012 Oct;26(5):849-56. doi: 10.1053/j.jvca.2011.11.006. Epub 2012 Jan 20. J Cardiothorac Vasc Anesth. 2012. PMID: 22265270 Free PMC article.
References
-
- Willson D.F., Notter R.H. The future of exogenous surfactant therapy. Respir Care. 2011;56:1369–1386. - PubMed
-
- Bernhard W., Pynn C.J., Jaworski A., et al. Mass spectrometric analysis of surfactant metabolism in human volunteers using deuteriated choline. Am J Respir Crit Care Med. 2004;170:54–58. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources